Mealey's Litigation Procedure - Illinois Federal Judge Will Exclude Testimony At Patent Trial

Mealey's Litigation Procedure - Illinois Federal Judge Will Exclude Testimony At Patent Trial

CHICAGO - Efforts by a plaintiff company to offer testimony by its vice president of new business ventures relating to the commercial success of the anticoagulant drug Angiomax were thwarted March 25 by an Illinois federal judge, who instead found that his testimony would incorporate "faulty" methodology (The Medicines Company v. Mylan Inc., et al., No. 11-1285, N.D. Ill.).

Find full version on lexis Advance®
Access this news story on lexis.com®